Core Insights - Plus Therapeutics has received approval for a new Category III CPT code from the American Medical Association to track the utilization of convection-enhanced delivery (CED) for REYOBIQ therapy in recurrent glioblastoma and pediatric brain cancer, marking a significant step towards market access and commercialization [1][2] Group 1: REYOBIQ Therapy - REYOBIQ (rhenium Re186 obisbemeda) is a novel injectable radiotherapy designed to deliver targeted high-dose radiation to CNS tumors, potentially improving patient outcomes compared to existing therapies [3] - The therapy is currently being evaluated in clinical trials for recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancer, with significant funding support from various institutions, including a $17.6 million grant from the Cancer Prevention & Research Institute of Texas [3] Group 2: Market Access and Utilization Tracking - The approved Category III CPT code, X566T, will facilitate the tracking of CED procedures for REYOBIQ, aiding in the evaluation of its clinical use and supporting future reimbursement and coverage decisions [2] - The new CPT code will be published on July 1, 2026, and will take effect for reporting on January 1, 2027, which is expected to enhance the adoption of REYOBIQ in clinical settings [2] Group 3: Company Overview - Plus Therapeutics is a clinical-stage pharmaceutical company based in Houston, Texas, focused on developing targeted radiotherapeutics for challenging CNS cancers, aiming to improve clinical outcomes through innovative treatment approaches [4] - The company has established a supply chain through strategic partnerships to support the development, manufacturing, and potential commercialization of its products [4]

MONTRÉAL, Feb. 25, 2026 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V NBY) (OTCQB: NBYCF), is proud to provide a new resource estimate (the “2026 MRE”) for the Crevier niobium (Nb) and tantalum (Ta) project (the “Crevier Project”), which is 72.5% owned by NioBay and 27.5 % by Niobec (a subsidiary of Magris Performance Materials Inc.). The Crevier Project is located approximately 50 km north of the town of Girardville and approximately 150 km from the Niobec mine. It lies within t ...

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – Vancouver, BC, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to announce its capital deployment strategy outlook for 2026. Humanoid Global intends to pursue a strategic ac ...

Crystal Works Agreement Drives South Asia Adoption of Wrap’s Integrated Non-Lethal Response and Training EcosystemMIAMI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in non-lethal response and public safety technology, today announced a strategic distribution agreement with Crystal Works Private Limited (“Crystal Works”), a premier supplier of advanced technology solutions for defense and law enforcement markets in India. The agreement i ...

LOUISVILLE, Ky., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in the Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per common share. The dividend will be paid on April 1, 2026, to stockholders of record as of March 16, 2026. Louisville, Kentuck ...

Core Insights - Amerigo Resources Ltd. reported strong financial results for 2025, with a net income of $35.4 million and basic earnings per share (EPS) of $0.22, reflecting a significant increase from the previous year [2][11] - The company returned $20.4 million to shareholders through dividends and share buybacks, marking the second year of full deployment of its Capital Return Strategy (CRS) [2][4] - The operational performance was bolstered by a 9% increase in the average annual London Metal Exchange (LME) copper price, which reached historical highs as of early 2026 [3][5] Financial Performance - In 2025, Amerigo achieved an EBITDA of $89.8 million and free cash flow to equity (FCFE) of $37.1 million, both showing substantial growth compared to 2024 [2][11] - The fourth quarter of 2025 saw a net income of $17.9 million and an EPS of $0.10, indicating strong quarterly performance [6][11] - Revenue for 2025 was $227.3 million, up from $192.8 million in 2024, driven by increased copper tolling revenue [11][18] Shareholder Returns - The company declared its eighteenth consecutive quarterly dividend of Cdn$0.04 per share, representing an annual dividend yield of 3.5% based on the closing share price of Cdn$4.54 [7][8] - Amerigo's share count was reduced by 2.8 million shares in 2025, and the company eliminated its debt, enhancing cash flow to shareholders [4][11] Operational Highlights - Copper production from Minera Valle Central (MVC) was 62.2 million pounds in 2025, slightly down from 64.6 million pounds in 2024, with an average copper price of $4.73 per pound [5][11] - The company reported a cash cost of $1.93 per pound in 2025, a slight increase from $1.89 per pound in 2024, attributed to rising labor and operational costs [11][27] Market Outlook - Amerigo remains optimistic about copper prices, citing strong market fundamentals and the potential for sustained high prices due to currency debasement [5][11] - The company plans to continue focusing on reliability, asset integrity, and long-term operational stability to support capital generation and returns to shareholders [5][11]

SAN FRANCISCO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Serve Robotics Inc. (“Serve”) (Nasdaq: SERV), a leading autonomous robotics company, today announced that it will report its 2025 fourth quarter financial results before the opening of regular trading on Wednesday, March 11, 2026. The company will host a conference call and webcast to review the results on the same day. Conference Call and Webcast InformationCompany management will host a conference call at 8 a.m. PT / 11 a.m. ET. A live audio webcast will be ...

CELEBRATION, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will present at the Citizens Life Sciences Conference in Miami Beach, FL on Wednesday, March 11, 2026, at 9:00 a.m. ET. Additionally, management will be available for one-on-one meetings with registered conference attendees. A link ...

VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX-V: RYO | OTC: RYOOF) is pleased to announce a non-brokered private placement financing for gross proceeds of up to $3,000,000 (the “Offering”). Under the Offering, subject to regulatory approval, the Company intends to issue up to 8,571,429 units (the “Units”) at a price of $0.35 per Unit. Each Unit will consist of one common share of the Company and one-half (1/2) of one common share purchase ...

Delivered strong full year 2025 resultsCompleted Initial Public OfferingIntroduced full year 2026 guidanceFourth quarter net sales of $7.8 billion, an increase of 14.8%Fourth quarter net income of $180 million, a decrease of 37.7%Fourth quarter Adjusted EBITDA1 of $805 million, approximately flatFull year net sales of $28.4 billion, an increase of 11.5%Full year net income of $1.2 billion, a decrease of 3.6%Full year Adjusted EBITDA1 of $3.5 billion, an increase of 3.2% NORTHFIELD, Ill., Feb. 25, 2026 (GLOB ...